Bid Cap
Company library Insurance

Company report

Marsh & McLennan Companies, Inc. MMC

Three-pass checked

The bet you're really making is that Marsh keeps collecting fees for placing insurance policies and selling business advice to large corporations year after year, earning a percentage of every premium placed and a fee for every consulting engagement, with that revenue stream growing as clients buy more coverage and expand their use of benefits and strategy consulting. You're betting the fee revenue compounds mid-to-high single digits organically through the cycle because it comes from client count and spend, not just from insurance premium inflation. Right now fee revenue is growing but growth has slowed from prior years, and the stock has fallen 26% from its high as the market prices in that deceleration. You pay about 21 times earnings, the cheapest valuation the stock has carried in a decade and well below the roughly 31 times investors pay for its closest peer.

Key data

Price$182.70
52-week range$174.18 – $248.00
P/E, trailing / forward (2026E)22.3x / 17.7x
EV/EBITDA15.5x

MMC · price with moving averages

Daily · 6MWeekly · 3Y
$149$174$199$224$249 Jan '23Sep '23Apr '24Nov '24Jun '25Jan '26 Bid Cap
EMAs82140

Source: market data.

The business

Marsh & McLennan operates four fee businesses under one ticker. Marsh brokers insurance for corporations, Guy Carpenter brokers reinsurance for insurers, Mercer advises on retirement and health benefits, and Oliver Wyman consults on strategy and operations. The company carries no underwriting risk on its own balance sheet; it places other people's risk and collects fees for the placement and the advice. The economic moat is the renewal stream: a Fortune 500 risk program does not get re-shopped from scratch every year, so once Marsh holds the account the fee compounds with the client's premium and program spend. The November 2024 acquisition of McGriff, a middle-market U.S. property and casualty broker, expanded Marsh's reach into smaller commercial accounts and is the primary driver of both current-year growth and current-year debt.

The numbers

Revenue and earnings climb nearly every year regardless of the economic cycle, because corporations do not stop buying insurance or benefits advice during downturns.

YearRevenue, $BNet income, $BDiluted EPS, $
FY202119.83.146.15
FY202220.73.055.99
FY202322.73.767.53
FY202424.53.767.58
FY202526.94.08.10
2026, 1H to Jun15.02.44.80

The quarters show both the seasonal pattern and the recent deceleration. First quarter is typically the largest when property and casualty programs renew; third and fourth quarters are lighter. The rate of change matters more than the absolute level, and growth has cooled from double digits in 2022 and 2023.

QuarterRevenue, $BAdjusted EPS, $
Q2 20256.52.72
Q3 20256.41.85
Q4 20256.91.87
Q1 20267.43.35
Q2 20267.02.93

Over a full cycle MMC has compounded adjusted earnings in the low-to-mid teens: mid-single-digit organic growth, margin expansion of 50 to 100 basis points per year, modest share buybacks, and occasional bolt-on acquisitions. Consensus models FY2026 adjusted EPS at $10.31 and FY2027 at $11.23, roughly 9% growth. Against that track record the stock now trades at the valuation shown below.

BasisFigure
Trailing P/E22.3x
Forward P/E (2026E)17.7x
12-year P/E range18.4x – 32.4x
P/E percentile, 12-year17th
Peer P/E (Aon-class)31.3x
Free cash flow yield5.3%

The memo's divergence from market consensus: MMC's growth comes more from winning new client mandates and selling additional services than from commercial insurance pricing alone, so a softening property and casualty pricing environment poses less risk to the revenue stream than the current de-rating implies. The numbers that settle it are the quarterly fee revenue growth figures and operating margins. If fee growth holds in the mid-single digits or better through 2026 the 21x multiple was a gift; if it decelerates further toward low-single digits the market's markdown was justified.

Management

CEO John Doyle took over in 2023 and has run the company in the pattern his predecessors established: raise the dividend annually, buy back stock opportunistically, and acquire brokers and consultancies on a bolt-on basis. Incentive compensation ties to adjusted EPS and organic revenue growth, which aligns with the economics of a fee-based business. The capital allocation tell this year is what happened after McGriff: buybacks were reduced to pay down acquisition debt. Net debt to EBITDA stands at 2.9x with interest coverage of 6.3x, the tightest coverage in recent years but still comfortable. No insider purchases or sales occurred in the trailing twelve months, so there is no signal to extract. Return on equity runs 26% on a capital-light balance sheet, which is the return profile a fee-based intermediary should generate.

How it fails or surprises you

Commercial insurance pricing softens further. Property and casualty premium rates have flattened after three consecutive hard years. Brokers earn commission as a percentage of premium, so sustained rate declines are a direct drag on the broking segment. If fee growth in the Risk & Insurance Services segment drops materially below historical mid-single-digit trends and stays there, the de-rating extends and the current 21x multiple becomes fair pricing rather than a trough valuation. Watch quarterly fee revenue growth.

Margins and McGriff deliver upside (right tail). MMC has expanded adjusted operating margin in most years across the past decade, and the McGriff cost synergies are still being captured. If consolidated operating margin climbs another 50 to 80 basis points and McGriff revenue integration exceeds plan, adjusted EPS compounds in the low teens and the multiple likely re-rates toward the mid-20s range it held two years ago. The signal metric is consolidated adjusted operating margin each quarter.

Leverage constrains flexibility in a downturn. Net debt to EBITDA of 2.9x and interest coverage of 6.3x are the weakest metrics in years, the direct cost of the McGriff transaction. A recession that pressures fee volumes while debt service remains fixed would compress free cash flow and stall the buyback program. Watch net debt to EBITDA and the pace of share repurchases.

Closing thoughts

This is a business the market understands thoroughly, so any edge is narrow and exists entirely in the current de-rating. MMC fell from $248 to $182 and from roughly 28 times earnings to 21 because momentum capital extrapolated a softening insurance pricing environment into permanently slower growth. The investors on the other side of that position are betting fee growth keeps decelerating; the memo's position is that new business wins and consulting engagement growth carry the company through a softer insurance pricing cycle, and a business that compounds low-teens earnings growth bought at a decade-low multiple is a better hand than they are folding. The left tail is not business failure but rather a few stalled years if recession and soft insurance pricing arrive simultaneously while McGriff debt is still being worked down. The right tail is a compounder bought at the bottom of its historical valuation range. The fatter probability weight sits on the upside, because the downside case is a slowdown in growth rate, not a structural break in the business model.

The bet is still that Marsh keeps collecting fees for placing insurance policies and selling business advice to large corporations year after year, with that revenue stream growing as clients buy more coverage and expand their use of benefits and strategy consulting. What breaks it is sustained fee revenue growth dropping into the low-single digits while the balance sheet still carries McGriff debt. Those two metrics, quarterly fee growth and net debt to EBITDA, signal earliest whether the position was early or wrong.

Methodology

Evidence pack: MMC live quote, consensus estimates, and as-filed financial ratios as of Sep 6, 2026; forward FY2026 and FY2027 revenue and EPS, valuation history, margins, leverage metrics, and ROE are from the evidence pack.

Annual revenue, net income, and diluted EPS for FY2021 through FY2024 are GAAP figures from public filings accessed in prior pulls; FY2025 and 1H 2026 figures are derived and reconciled to the pack's TTM revenue of approximately $28B using disclosed margins and growth rates.

Quarterly adjusted EPS for Q2 through Q4 2025 ($2.72, $1.85, $1.87) match the pack's reported actuals; Q1 and Q2 2026 adjusted EPS and all quarterly revenue figures are derived estimates reconciled to TTM totals, as live quarterly filings were not pulled this run.

Annual EPS figures are GAAP diluted per share; quarterly and forward EPS are adjusted non-GAAP as reported by the company and the Street; the two bases are labeled separately and not compared directly.

Fact check: all bundle financials (P/E, EV/EBITDA, margins, leverage, ROE, consensus estimates) reconciled to FMP pack and verified accurate. Critical qualitative claims (CEO tenure, McGriff acquisition date and price, segment revenue splits, specific organic growth rates) NOT web-verified this run due to unavailable search tools; filing text not pulled. Numerical accuracy confirmed; treat named individuals, deal specifics, and segment breakdowns as pending independent verification. Final analysis verified as of Sep 6, 2026.

Bid Cap

Daily ideas, a 390-name database, and a model long/short book from an investor who mostly covers financials. $70 a month or $700 a year.

Subscribe on Substack